Matthew Downham, CEPI’s director of manufacturing and supply chain networks, tells GEN, “Through this partnership, CEPI and Samsung Biologics will establish a pre-agreed, ready-to-activate ...

In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

The new childhood immunization policies and vaccine schedule from the U.S. Department of Health and Human Services is the focus of yet another multistate lawsuit, with Michigan Attorney General Dana ...

Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ...

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna’s portfolio.

As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with Moderna to produce vaccines domestically.  | The agreement includes mRNA vaccine ...

A model of a new vaccine targeting a family of coronaviruses that includes the virus that causes COVID-19. The image highlights pieces of several different viruses attached to a computer-designed ...

Despite the worldwide effort to develop safe and effective vaccines against COVID-19 and ramp up production capacity, it is inevitable that initial vaccine supply will be limited. Therefore, ...

Public health debates often sound abstract until policy decisions start to land in pediatric clinics, schools and family kitchens. Right now, recommendations are circulating within the Department of ...

Emergent BioSolutions Inc. (NYSE: EBS) stock rose in Friday premarket trading. On Thursday, New York Attorney General Letitia James sued former chief executive Robert G. Kramer over alleged insider ...